Frontlight ResearchEarly access
Trial site
NTT Medical Center Tokyo
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Myelodysplastic syndromes2 trials
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Myeloproliferative neoplasms1 trial
- Stroke1 trial
- Phase
- Phase 33 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting7 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- Janssen Research & Development, LLC2 trials
- CathWorks Ltd.1 trial
- Incyte Corporation1 trial
- North East Japan Study Group1 trial
- and 2 more
Running trials
Recruiting
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Active, not recruiting
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
Active, not recruiting
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myelodysplastic syndromes1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026